Narcolepsy Clinical Trials

Narcolepsy clinical trials are research studies that test medicines, devices, or ways of managing narcolepsy. Some study drugs still in development, others compare treatments already on the market. Every trial follows a strict protocol reviewed by an independent ethics board before anyone can enroll.

Until August 2026, every approved narcolepsy medicine only managed symptoms rather than the underlying cause. Clinical trials are how new approaches, like the orexin receptor agonists now reaching the market, get tested and eventually reach patients. Every treatment option available today exists because someone volunteered for a trial first.

Eligibility depends on the specific study, but many trials look for adults diagnosed with narcolepsy type 1 or type 2 through a sleep study. Some require stopping current stimulant medication for a short washout period before joining. Studies increasingly welcome people who are newly diagnosed, since much of the research history has focused on long term patients. Eligibility always varies by study.

Narcolepsy trials generally fall into a few groups. Some test drugs, like orexin receptor agonists that aim to restore the brain chemical missing in narcolepsy type 1. Others study existing medicines in new age groups or combinations, and some are observational studies that track symptoms over time without testing a treatment.

Some studies offer compensation for time and travel, and study related care is typically provided at no cost to participants. Compensation varies by trial and is always described during the informed consent process before you agree to anything.

Curious whether clinical trials pay participants? Here's how compensation actually works.

How Much do Clinical Trials Pay? Everything You Need to Know About Getting Paid For Clinical Trials

Browse the studies listed on this page and apply to the ones that fit your situation, it takes about 5 minutes. Our team confirms eligibility with you and connects you with the research site.